Literature DB >> 8061448

Gd-DTPA-cascade-polymer: potential blood pool contrast agent for MR imaging.

G Adam1, J Neuerburg, E Spüntrup, A Mühler, K Scherer, R W Günther.   

Abstract

Gadolinium-DTPA (diethylenetriaminepentaacetic acid)-cascade-polymer, a potential new blood pool contrast agent for magnetic resonance (MR) imaging, was compared with a known blood pool agent, Gd-DTPA-polylysine, in an animal model. The relative signal intensities of liver, renal cortex, pancreas, and trunk muscle were assessed in 12 pigs between 4 seconds and 120 minutes after injection of a 20 mumol/kg dose of each contrast agent, by using a FLASH (fast low-angle shot) sequence. Except for muscle, all tissues showed visible enhancement after injection of either contrast agent. After injection of Gd-DTPA-polymer, enhancement patterns in the liver, renal cortex, and pancreas were similar to those seen after injection of Gd-DTPA-polylysine. No statistically significant differences in enhancement between the two contrast agents were found at any time point. The authors conclude that the contrast kinetics of Gd-DTPA-cascade-polymer are similar to those of Gd-DTPA-polylysine and that this agent may also be used as a blood pool contrast agent for MR imaging.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8061448     DOI: 10.1002/jmri.1880040336

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  10 in total

1.  Strategies for the preparation of bifunctional gadolinium(III) chelators.

Authors:  Luca Frullano; Peter Caravan
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

Review 2.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  1H-NMRD and 17O-NMR assessment of water exchange and rotational dynamics of two potential MRI agents: MP-1177 (an extracellular agent) and MP-2269 (a blood pool agent).

Authors:  K Adzamli; E Toth; M P Periasamy; S H Koenig; A E Merbach; M D Adams
Journal:  MAGMA       Date:  1999-08       Impact factor: 2.310

4.  Deuterium NMR study of the MP-2269: albumin interaction--a step forward to the dynamics of non-covalent binding.

Authors:  K Adzamli; L Vander Elst; S Laurent; R N Muller
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.310

Review 5.  Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening.

Authors:  Michael A Bruckman; Xin Yu; Nicole F Steinmetz
Journal:  Nanotechnology       Date:  2013-10-24       Impact factor: 3.874

Review 6.  Gadolinium-based contrast agents for magnetic resonance cancer imaging.

Authors:  Zhuxian Zhou; Zheng-Rong Lu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-10-09

7.  Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent.

Authors:  B Misselwitz; H Schmitt-Willich; W Ebert; T Frenzel; H J Weinmann
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.533

8.  P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results.

Authors:  M Port; C Corot; O Rousseaux; I Raynal; L Devoldere; J M Idée; A Dencausse; S Le Greneur; C Simonot; D Meyer
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.533

Review 9.  Design and Synthesis of Luminescent Lanthanide-Based Bimodal Nanoprobes for Dual Magnetic Resonance (MR) and Optical Imaging.

Authors:  Walid Mnasri; Mahsa Parvizian; Souad Ammar-Merah
Journal:  Nanomaterials (Basel)       Date:  2021-02-01       Impact factor: 5.076

Review 10.  Nanoparticles for multimodal in vivo imaging in nanomedicine.

Authors:  Jaehong Key; James F Leary
Journal:  Int J Nanomedicine       Date:  2014-01-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.